Skip to contentSkip to Braille Studio

Library / Laws / 113th Congress / House Bills / H.R. 413

H.R. 413

To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012.

Print stageDateSize⠃
Introduced in House2013-01-231.1K⠃⠗⠋